VDP-147: Catalyst Beta Program: Funding Experiment for Longevity Research Moonshots

One-liner: Allocate up to $100k to fund early-stage longevity research moonshots through Catalyst.

Team: @alexdobrin , @tylergolato , @vincent, @timrpeterson

Objective: Collaborate with Catalyst to fund and accelerate high-potential longevity research moonshots, turning successfully funded projects into IPTs.

VitaDAO gets access to potential moonshot projects and the opportunity to direct Catalyst in finding projects of interest. Through Catalyst, it gains projects with early funder engagement that can potentially become part of the VitaDAO community.

There's no downside, only upside. The $100k won't be locked for Catalyst, the VitaDAO community will ultimately decide if they want to pursue funding the projects found.

VitaDAO tries multiple ways of reaching the mandate goal in order it makes sure it reached 10 IPTs by 2025

Background:

Catalyst connects researchers, biotech experts, and funders to advance translational research. This collaboration aims to support longevity research, bridging the gap from academic research to market-ready health solutions. This initiative aligns with VitaDAO's mandate to fund 10 IPTs during 2024-2025.

Project Details:

Funding Amount: Up to $100,000

Research Focus: Early-stage longevity research

Expected Outcomes: Fund up to 3 high-potential projects with expert guidance and funder engagement.

Implementation Plan:

Sourcing Projects: Catalyst will source projects, and VitaDAO can request specific types or submit suggestions.

Funding Approval: When a project meets the funding criteria, the team will make a governance proposal for VitaDAO tokenholders to approve the funding.

Conclusion:This collaboration with the Catalyst Beta Program will significantly contribute to VitaDAO’s mission by funding promising early-stage projects, experimenting with web3 ways of funding and sourcing science like Catalyst.